Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Covid-19 Diagnostics Market Outlook and Findings

  • [280 Pages Report] The Covid-19 diagnostics market players look to develop highly sensitive and specific testing kits
  • RT-PCR remains the most widely used diagnostic test globally
  • Leading players boosting production by launching automated COVID-19 testing systems
  • Springing up of local players to combat Covid-19 providing a competitive edge to the market

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Covid-19: A Snapshot

As of now, the world is battling Covid-19. The name “Covid-19” says “Corona Virus Disease -2019” as the first traces were found in human body in 2019.

The term “Corona Virus” is coined regarding the family of viruses that get transmitted between humans and animals. As such, they are also called “zoonotic viruses”.

By the end of Mar 2020, the WHO confirmed that Covid-19 outbreak has spread to 213 countries across 6 continents.

The common symptoms observed are dry cough, fatigue, fever, sore throat, shortness of breath, body pain/ache, and even diarrhea in a few cases. At times, runny nose and nausea are also observed.

Till recently, this infection was reported to spread from person to person through saliva or nasal discharge, especially on the infected person sneezing or coughing. However, of late, WHO issued guidelines for airborne transmission as well. The time between a person getting exposed to Covid-19 and onset of symptoms is usually 12-14 days.

Key Market Trends

RT PCR (Reverse Trascriptase PCR) remains the preferred mode of treatment for coronavirus testing. This technique is advantageous such that primers used can be produced with utmost speed.

As such, multiplex RT PCR is the most preferred diagnostic test with regards to Covid-19. Many molecular diagnostics companies are focusing on developing affordable RT PCR tests.

Along the above-mentioned lines, efforts are being taken by certain players to cater to the increasing number of Covid-19 affected patients. They are likely to substantiate the Covid-diagnostics market in the forecast period (2020-2030).

For instance –

  • In Jul 2020, Avacta announced beginning of clinical validation of high throughput Covid-19 laboratory test (Adeptrix Covid-19 diagnostic test) by collaborating with CONDOR program by the government of UK
  • In Jul 2020, BATM launched 3 novel diagnostic kits, namely – Covid-19 serologic test, Covid-19 antigen test, and new molecular diagnostics test for advancing Covid-19’s diagnosis
  • In July 2020, Mylab launched “Compact XL”, a machine for automating all the manual processes of molecular diagnostic tests, inclusive of Covid-19’s RT-PCR tests
  • In Jul 2020, The National Institute of Health selected the rapid Covid-19 test under the Rapid Acceleration of Diagnostics Tech (RADx Tech) program. Researchers at MIT, along with 3M have started with an accelerated research to check if a simple device could produce accurate results and its feasibility regarding mass production
  • In Jul 2020, Quest Diagnostics received authorization from the US FDA regarding laboratory technique to be employed in Covid-19 diagnostic testing
  • In June 2020, T2 Biosystems, Inc. announced that it had finished with validation of Covid-19 molecular diagnostic test – the “T2SARS-CoV-2 Panel” under license agreement with Hackensack Meridian Health’s Center of Discovery and Innovation. Distribution at the commercial level has been permitted after having met requirements for an EUA (Emergency Use Authorization) request to the US FDA
  • In Jun 2020, Mobidiag received CE-IVD markings relating to the two tests enabling reliable and rapid detection of Covid-19. They are – Amplidiag Covid-19 for catering to large laboratories for batch volume tests and Novodiag Covid-19 for on-demand, single tests
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Research and Offbeat Discoveries to Drive the Market

Apart from the market players, educational and research institutes are putting their best foot forward to develop safer and quicker coronavirus diagnostic test kits.

For instance –

  • In Jul 2020, AdvaMed announced creation of an exhaustive national Covid-19 diagnostic supply registry for lending a helping hand to federal and state pandemic responses.
  • In Jul 2020, The Journal of the American Osteopathic Association published a research paper that stated that obtaining eosinophil count also helps in detection of Covid-19. It also presented that out of Covid-19 patients, 60% did have zero eosinophils at presentation. The once not affected had not more than 16%.
  • India-based IIT Delhi, in Jul 2020, launched “Corosure”, the Covid-19 test kit at a base price of US $5 only.
  • In Jul 2020, SRL Diagnostics, in collaboration with Fortis Hospital, decided to launch antigen test facility to diagnose Covid-19 in Karnataka, India.

Players to fill the Void for asymptomatic Patients

Recently, several people who had shown no symptoms of Covid-19 have been reported to have contracted Covid-19. This has actually put the healthcare personnel in a fix, as there is no way out other than mass testing.

To enable this testing at a large scale, Covid-19 testing kits also need to be available in large numbers. For instance – Roche’s testing head mentioned that demand for equipment for processing Covid-19 tests has increased to the levels it would normally see over 4 to 5 years.

On these grounds, the company is planning to introduce novel antibody tests by the end of 2020 to widen its offering pertaining to the same.

Moreover, local players across the globe are trying their best to table Covid-19 test kits, so that detection gets speeded up and so do the medications. For instance – In Apr 2020, FastSense Diagnostics, an India-based start-up, developed rapid diagnostic kits to screen Covid-19.

Similarly, South Korea-based SD Biosensor, in Apr 2020, obtained the license to produce Covid-19 test kits in India. Also, Voxtur Bio, around the same time, started manufacturing rapid test kits to address Covid-19.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Covid-19 Diagnostics Market: Regional Analysis

Covid-19 Diagnostics Market

The Covid-19 pandemic has taken the entire world on a ride. As of now, the US, Russia, Italy, Spain, Brazil, India, Australia are amongst the worst affected countries. As such, North America, Europe, Latin America, Oceania, Asia-Pacific – all the continents are battling Covid-19. Right now, there are 14,971,036 confirmed cases, inclusive of 618,017 deaths, as reported by the WHO.

Americas is top-seeded with 7,948,513, Europe stands second with 3,124,701, and South-East Asia with 1,571,317 confirmed cases. So, Americas are requiring the highest number of Covid-19 test kits. The status quo is expected to remain the same in the subsequent quarters as it will definitely take time for Covid-19 to reach the “below par” mark.

Also, Switzerland and Czech Republic have increasing testing capacity on their part in the last few months. As far as Asia Pacific is concerned, profitable partnership initiatives amongst India, South Korea, Japan regarding penetration of Covid-19 diagnostic products are expected to bolster the market

Major Players in the Covid-19 Diagnostics Market

The key players are into accelerating production as well as supply of Covid-10 diagnostic test kits for keeping pace with requirement for disease containment. For example – Roche, in Mar 2020, did initiate shipment of Cobas SARS-CoV-2 test kits’ first allotment.

Around 400,000 test kits were shipped all across the US hospitals and reference laboratories. Likewise, it started shipping additional 400,000 additional test kits every week.

Likewise, the players are working on collaborative approach to cope with Covid-19 crisis and also expand business. For instance, Quest Diagnostics, in May 2020, collaborated with Ortho Clinical Diagnostics with the objective of expanding Covid-19 testing across 20+ labs all through the US. Ortho’s VITROS Immunodiagnostic products Anti-SARS-CoV-2 IgG test for speeding up Covid-19 testing in the patients.

The other major players include:

  • Veredus Laboratories
  • Thermo Fisher Scientific, Inc.
  • Quidel Corporation
  • Perkin Elmer, Inc.
  • Neuberg Diagnostics
  • Mylab Discovery Solutions Pvt Ltd.
  • Luminex Corporation
  • Laboratory Corporation of America Holdings
  • Hologic Inc.
  • Danaher
  • Cepheid
  • bioMérieux SA
  • Altona Diagnostics GmbH
  • ALDATU BIOSCIENCES
  • ADT Biotech Sdn Bhd
  • Abbott
  • 1drop Inc.

Covid-19 Diagnostics market: The Way Forward

The Covid-19 diagnostics market is expected to go strong in the upcoming period. Even when a vaccine is eventually developed, testing will still be around, as inoculating entire population will take time.

The market players are already on to the expansion spree in terms of production of diagnostic kits. However, they need to devise ways to mellow down on the costs, which is one of the most competitive factors for them at the global level. The local players are already giving them a tough fight in this regard.

Key Segment

Product Type

  • Instruments
  • Test Kits
  • Reagents and Consumables

Sample Type

  • Oropharyngeal & Nasopharyngeal Swabs
  • Blood
  • Urine
  • Others

Technology

  • PCR
  • ELISA
  • POC

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Frequently Asked Questions

What is the Growth Outlook for Covid-19 Diagnostics Market?

The covid-19 diagnostics market is likely to secure a CAGR of 7.7% through 2032.

By 2032, how much can the Covid-19 Diagnostics Market Grow?

The covid-19 diagnostics market size is estimated to cross US$ 204.51 Bn by 2032.

What is the Current Valuation of the Covid-19 Diagnostics Market?

The covid-19 diagnostics market is likely to record a value of US$ 97.4 Bn in 2022.

Which Region is likely to Lead the Covid-19 Diagnostics Market?

Europe is likely to lead the covid-19 diagnostics market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Technology Adoption / Usage Analysis

    4.2. Key Product Features and their USPs

    4.3. Key Promotional Strategies, By Manufacturers

    4.4. Regulations, By Region

5. Global Market (Volume in Units) Analysis 2015-2019  and Forecast, 2020-2030

    5.1. Historical Market Volume (in Units) Analysis, 2015-2019

    5.2. Current and Future Market Volume (in Units) Projections, 2020-2030

6. Global Market - Pricing Analysis

    6.1. Average Pricing Analysis By Region

    6.2. Pricing Break-up

        6.2.1. Manufacturer Level Pricing

        6.2.2. Distributor Level Pricing

    6.3. Global Average Pricing Analysis Benchmark

7. Global Market Demand (Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

    7.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Market Background

    8.1. Macro-Economic Factors

        8.1.1. Global GDP Growth Outlook

        8.1.2. Per Capita Healthcare Expenditure Outlook

    8.2. Forecast Factors - Relevance & Impact

        8.2.1. Increase in R&D Funding and Grants

        8.2.2. Increase in Number of Corona Virus Disease Cases

        8.2.3. Diagnosis Seeking Rate

        8.2.4. COVID-19 Disease Mortality Rate

        8.2.5. Industry Consolidation to Increase Capacity

        8.2.6. Increase in Manufacturing Activity

    8.3. Market Dynamics

        8.3.1. Drivers

        8.3.2. Restraints

        8.3.3. Opportunity Analysis

    8.4. COVID19 Crisis Analysis

        8.4.1. Current COVID19 Statistics and Probable Future Impact

        8.4.2. Current GDP Projection and Probable Impact

        8.4.3. Current Economic Projection as compared to 2008 Economic analysis

        8.4.4. COVID19 and Impact Analysis

            8.4.4.1. Revenue By Product Type

            8.4.4.2. Revenue By Sample Type

            8.4.4.3. Revenue By Technology

            8.4.4.4. Revenue By End User

            8.4.4.5. Revenue By Country

        8.4.5. 2020 Market Scenario

        8.4.6. Quarter by Quarter Forecast

        8.4.7. Projected recovery Quarter

        8.4.8. Recovery Scenario – Short term, Midterm and Long Term Impact

9. Global Market Analysis 2015-2019 and Forecast 2020-2030, by Product Type

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2015-2019

    9.3. Current and Future Market Size (US$ Mn) & Volume Analysis and Forecast By Product Type, 2020-2030

        9.3.1. Instruments

        9.3.2. Test Kits

            9.3.2.1. Rapid Test Kits

            9.3.2.2. Assay Based Test Kits

        9.3.3. Reagents and Consumables

    9.4. Market Attractiveness Analysis By Product Type

10. Global Market Analysis 2015-2019 and Forecast 2020-2030, by Sample Type

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) By Sample Type, 2015-2019

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Sample Type, 2020-2030

        10.3.1. Oropharyngeal & Nasopharyngeal Swabs

        10.3.2. Blood

        10.3.3. Urine

        10.3.4. Others

    10.4. Market Attractiveness Analysis By Sample Type

11. Global Market Analysis 2015-2019 and Forecast 2020-2030, by Technology

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Technology, 2015-2019

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2020-2030

        11.3.1. PCR

        11.3.2. ELISA

        11.3.3. POC

    11.4. Market Attractiveness Analysis By Technology

12. Global Market Analysis 2015-2019 and Forecast 2020-2030, by End User

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2019

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020-2030

        12.3.1. Hospitals

        12.3.2. Speciality Clinics

        12.3.3. Diagnostic Centers

        12.3.4. Pathology Laboratories

        12.3.5. Research Institutes

    12.4. Market Attractiveness Analysis By End User

13. Global Market Analysis 2015-2019 and Forecast 2020-2030, by Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) & Volume Analysis By Region, 2015 - 2019

    13.3. Current Market Size (US$ Mn) & Volume Analysis and Forecast By Region, 2020 - 2030

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. East Asia

        13.3.5. South Asia

        13.3.6. Oceania

        13.3.7. Middle East and Africa (MEA)

    13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2015-2019 and Forecast 2020-2030

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019

    14.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030

        14.3.1.  By Country

            14.3.1.1. U.S.

            14.3.1.2. Canada

        14.3.2. By Product Type

        14.3.3. By Sample Type

        14.3.4. By Technology

        14.3.5. By End User

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. Latin America Market Analysis 2015-2019 and Forecast 2020-2030

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019

    15.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030

        15.3.1.  By Country

            15.3.1.1. Brazil

            15.3.1.2. Mexico

            15.3.1.3. Argentina

            15.3.1.4. Rest of Latin America

        15.3.2. By Product Type

        15.3.3. By Sample Type

        15.3.4. By Technology

        15.3.5. By End User

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. Europe Market Analysis 2015-2019 and Forecast 2020-2030

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019

    16.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030

        16.3.1.  By Country

            16.3.1.1. Germany

            16.3.1.2. Italy

            16.3.1.3. France

            16.3.1.4. U.K.

            16.3.1.5. Spain

            16.3.1.6. BENELUX

            16.3.1.7. Russia

            16.3.1.8. Rest of Europe

        16.3.2. By Product Type

        16.3.3. By Sample Type

        16.3.4. By Technology

        16.3.5. By End User

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. South Asia Market Analysis 2015-2019 and Forecast 2020-2030

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019

    17.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030

        17.3.1.  By Country

            17.3.1.1. India

            17.3.1.2. Thailand

            17.3.1.3. Indonesia

            17.3.1.4. Malaysia

            17.3.1.5. Rest of South Asia

        17.3.2. By Product Type

        17.3.3. By Sample Type

        17.3.4. By Technology

        17.3.5. By End User

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. East Asia Market Analysis 2015-2019 and Forecast 2020-2030

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019

    18.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030

        18.3.1.  By Country

            18.3.1.1. China

            18.3.1.2. Japan

            18.3.1.3. South Korea

        18.3.2. By Product Type

        18.3.3. By Sample Type

        18.3.4. By Technology

        18.3.5. By End User

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. Oceania Market Analysis 2015-2019 and Forecast 2020-2030

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019

    19.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030

        19.3.1.  By Country

            19.3.1.1. Australia

            19.3.1.2. New Zealand

        19.3.2. By Product Type

        19.3.3. By Sample Type

        19.3.4. By Technology

        19.3.5. By End User

    19.4. Market Attractiveness Analysis

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Market Analysis 2015-2019 and Forecast 2020-2030

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019

    20.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030

        20.3.1.  By Country

            20.3.1.1. GCC Countries

            20.3.1.2. Turkey

            20.3.1.3. South Africa

            20.3.1.4. Rest of Middle East and Africa

        20.3.2. By Product Type

        20.3.3. By Sample Type

        20.3.4. By Technology

        20.3.5. By End User

    20.4. Market Attractiveness Analysis

    20.5. Key Market Participants - Intensity Mapping

    20.6. Drivers and Restraints - Impact Analysis

21. Key and Emerging Countries Market Analysis 2015-2019 and Forecast 2020-2030

    21.1. Introduction

        21.1.1. Market Value Proportion Analysis, By Key Countries

        21.1.2. Global Vs. Country Growth Comparison

    21.2. U.S. Market Analysis

        21.2.1. By Product Type

        21.2.2. By Sample Type

        21.2.3. By Technology

        21.2.4. By End User

    21.3. Canada Market Analysis

        21.3.1. By Product Type

        21.3.2. By Sample Type

        21.3.3. By Technology

        21.3.4. By End User

    21.4. Mexico Market Analysis

        21.4.1. By Product Type

        21.4.2. By Sample Type

        21.4.3. By Technology

        21.4.4. By End User

    21.5. Brazil Market Analysis

        21.5.1. By Product Type

        21.5.2. By Sample Type

        21.5.3. By Technology

        21.5.4. By End User

    21.6. U.K. Market Analysis

        21.6.1. By Product Type

        21.6.2. By Sample Type

        21.6.3. By Technology

        21.6.4. By End User

    21.7. Germany Market Analysis

        21.7.1. By Product Type

        21.7.2. By Sample Type

        21.7.3. By Technology

        21.7.4. By End User

    21.8. France Market Analysis

        21.8.1. By Product Type

        21.8.2. By Sample Type

        21.8.3. By Technology

        21.8.4. By End User

    21.9. Italy Market Analysis

        21.9.1. By Product Type

        21.9.2. By Sample Type

        21.9.3. By Technology

        21.9.4. By End User

    21.10. Spain Market Analysis

        21.10.1. By Product Type

        21.10.2. By Sample Type

        21.10.3. By Technology

        21.10.4. By End User

    21.11. BENELUX Market Analysis

        21.11.1. By Product Type

        21.11.2. By Sample Type

        21.11.3. By Technology

        21.11.4. By End User

    21.12. Russia Market Analysis

        21.12.1. By Product Type

        21.12.2. By Sample Type

        21.12.3. By Technology

        21.12.4. By End User

    21.13. China Market Analysis

        21.13.1. By Product Type

        21.13.2. By Sample Type

        21.13.3. By Technology

        21.13.4. By End User

    21.14. Japan Market Analysis

        21.14.1. By Product Type

        21.14.2. By Sample Type

        21.14.3. By Technology

        21.14.4. By End User

    21.15. South Korea Market Analysis

        21.15.1. By Product Type

        21.15.2. By Sample Type

        21.15.3. By Technology

        21.15.4. By End User

    21.16. India Market Analysis

        21.16.1. By Product Type

        21.16.2. By Sample Type

        21.16.3. By Technology

        21.16.4. By End User

    21.17. ASEAN Market Analysis

        21.17.1. By Product Type

        21.17.2. By Sample Type

        21.17.3. By Technology

        21.17.4. By End User

    21.18. Australia Market Analysis

        21.18.1. By Product Type

        21.18.2. By Sample Type

        21.18.3. By Technology

        21.18.4. By End User

    21.19. New Zealand Market Analysis

        21.19.1. By Product Type

        21.19.2. By Sample Type

        21.19.3. By Technology

        21.19.4. By End User

    21.20. GCC Countries Market Analysis

        21.20.1. By Product Type

        21.20.2. By Sample Type

        21.20.3. By Technology

        21.20.4. By End User

    21.21. Turkey Market Analysis

        21.21.1. By Product Type

        21.21.2. By Sample Type

        21.21.3. By Technology

        21.21.4. By End User

    21.22. South Africa Market Analysis

        21.22.1. By Product Type

        21.22.2. By Sample Type

        21.22.3. By Technology

        21.22.4. By End User

22. Market Structure Analysis

    22.1. Market Analysis by Tier of Companies

    22.2. Market Concentration

    22.3. Market Share Analysis of Top Players

    22.4. Market Presence Analysis

        22.4.1. By Regional footprint of Players

        22.4.2. Product foot print by Players

        22.4.3. Channel Foot Print by Players

23. Competition Analysis

    23.1. Competition Dashboard

    23.2. Competition Benchmarking

    23.3. Competition Deep Dive

        23.3.1. Thermo Fisher Scientific, Inc.

            23.3.1.1. Overview

            23.3.1.2. Product Portfolio

            23.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.1.4. Sales Footprint

            23.3.1.5. Strategy Overview

                23.3.1.5.1. Marketing Strategy

                23.3.1.5.2. Product Strategy

                23.3.1.5.3. Channel Strategy

        23.3.2. Danaher

            23.3.2.1. Overview

            23.3.2.2. Product Portfolio

            23.3.2.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.2.4. Sales Footprint

            23.3.2.5. Strategy Overview

                23.3.2.5.1. Marketing Strategy

                23.3.2.5.2. Product Strategy

                23.3.2.5.3. Channel Strategy

        23.3.3. F. Hoffman-La Roche Ltd.

            23.3.3.1. Overview

            23.3.3.2. Product Portfolio

            23.3.3.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.3.4. Sales Footprint

            23.3.3.5. Strategy Overview

                23.3.3.5.1. Marketing Strategy

                23.3.3.5.2. Product Strategy

                23.3.3.5.3. Channel Strategy

        23.3.4. Hologic Inc.

            23.3.4.1. Overview

            23.3.4.2. Product Portfolio

            23.3.4.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.4.4. Sales Footprint

            23.3.4.5. Strategy Overview

                23.3.4.5.1. Marketing Strategy

                23.3.4.5.2. Product Strategy

                23.3.4.5.3. Channel Strategy

        23.3.5. Laboratory Corporation of America Holdings

            23.3.5.1. Overview

            23.3.5.2. Product Portfolio

            23.3.5.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.5.4. Sales Footprint

            23.3.5.5. Strategy Overview

                23.3.5.5.1. Marketing Strategy

                23.3.5.5.2. Product Strategy

                23.3.5.5.3. Channel Strategy

        23.3.6. Luminex Corporation

            23.3.6.1. Overview

            23.3.6.2. Product Portfolio

            23.3.6.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.6.4. Sales Footprint

            23.3.6.5. Strategy Overview

                23.3.6.5.1. Marketing Strategy

                23.3.6.5.2. Product Strategy

                23.3.6.5.3. Channel Strategy

        23.3.7. Mylab Discovery Solutions Pvt Ltd.

            23.3.7.1. Overview

            23.3.7.2. Product Portfolio

            23.3.7.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.7.4. Sales Footprint

            23.3.7.5. Strategy Overview

                23.3.7.5.1. Marketing Strategy

                23.3.7.5.2. Product Strategy

                23.3.7.5.3. Channel Strategy

        23.3.8. Neuberg Diagnostics

            23.3.8.1. Overview

            23.3.8.2. Product Portfolio

            23.3.8.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.8.4. Sales Footprint

            23.3.8.5. Strategy Overview

                23.3.8.5.1. Marketing Strategy

                23.3.8.5.2. Product Strategy

                23.3.8.5.3. Channel Strategy

        23.3.9. Perkin Elmer, Inc.

            23.3.9.1. Overview

            23.3.9.2. Product Portfolio

            23.3.9.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.9.4. Sales Footprint

            23.3.9.5. Strategy Overview

                23.3.9.5.1. Marketing Strategy

                23.3.9.5.2. Product Strategy

                23.3.9.5.3. Channel Strategy

        23.3.10. Quest Diagnostics

            23.3.10.1. Overview

            23.3.10.2. Product Portfolio

            23.3.10.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.10.4. Sales Footprint

            23.3.10.5. Strategy Overview

                23.3.10.5.1. Marketing Strategy

                23.3.10.5.2. Product Strategy

                23.3.10.5.3. Channel Strategy

        23.3.11. Quidel Corporation

            23.3.11.1. Overview

            23.3.11.2. Product Portfolio

            23.3.11.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.11.4. Sales Footprint

            23.3.11.5. Strategy Overview

                23.3.11.5.1. Marketing Strategy

                23.3.11.5.2. Product Strategy

                23.3.11.5.3. Channel Strategy

        23.3.12. Merck KGaA

            23.3.12.1. Overview

            23.3.12.2. Product Portfolio

            23.3.12.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.12.4. Sales Footprint

            23.3.12.5. Strategy Overview

                23.3.12.5.1. Marketing Strategy

                23.3.12.5.2. Product Strategy

                23.3.12.5.3. Channel Strategy

        23.3.13. Veredus Laboratories

            23.3.13.1. Overview

            23.3.13.2. Product Portfolio

            23.3.13.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.13.4. Sales Footprint

            23.3.13.5. Strategy Overview

                23.3.13.5.1. Marketing Strategy

                23.3.13.5.2. Product Strategy

                23.3.13.5.3. Channel Strategy

        23.3.14. Abbott Laboratories

            23.3.14.1. Overview

            23.3.14.2. Product Portfolio

            23.3.14.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.14.4. Sales Footprint

            23.3.14.5. Strategy Overview

                23.3.14.5.1. Marketing Strategy

                23.3.14.5.2. Product Strategy

                23.3.14.5.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

Recommendations

Healthcare

Americas COVID-19 Testing Market

Published : January 2023

Healthcare

Coronavirus Immunoassay Market

Published : June 2022

Healthcare

COVID-19 Saliva Sampling Test Potential Market

Published : June 2022

Healthcare

Covid-19 Vaccine Development Tools Market

Published : May 2022

Explore Healthcare Insights

View Reports

Covid-19 Diagnostics Market